| |
|
|
|
ComplianceOnline, Online Event
2012-07-24
Why Should You Attend: This webinar will start off with a discussion on the thermal properties of a formulated product and how stabilizing excipients can affect these (the first step in any well designed and understood process and formulation). Next, the discussion will turn towards understanding the different types of biologically based products commonly encountered in modern pharmaceutical and diagnostic markets, and the problems with long term stability. The mechanisms and process of stabilization through targeted stabilizing excipients and lyophilization will be covered in great detail, in addition to understanding the analytical techniques used to develop and verify a suitable formulation and process.
Finally, the session will finish with a discussion on formulation and stabilization techniques for cells and viruses, which pose a very large challenge for the formulation and process development scientist. Learning Objectives: - Principles of biomolecule stabilization.
- Developing a stable biomolecule formulation through stabilizing excipients.
- High throughput screening of potential formulations.
- Stabilizing cells and modified (attenuated) live viruses.
Areas Covered in the Seminar: - Thermal properties of formulated products.
- Mechanisms of degradation (chemical and physical).
- Theory of physical stabilization of biologically based products.
- Process of choosing the best stabilization agents to use and their effects on the thermal properties.
- Analytical techniques used to develop and verify acceptable formulations and processes.
|
|
|
|
|
|
|
|
Organized by:
|
|
ComplianceOnline |
|
|
Invited Speakers:
|
|
J. Jeff Schwegman, Ph.D. is currently the founder and chief executive officer of AB BioTechnologies where he develops formulations and lyophilization cycles. Additionally, Dr. Schwegman specializes in speaking and consulting in parenteral pre-formulation, formulation, analytical, and lyophilization of both small molecules and large biomolecules. He also holds patents and develops new technologies within the lyophilization field.
Dr. Schwegman received his PhD from Purdue University in 2003, and returned to Bloomington where he worked at Baxter Pharmaceutical Solutions as a Research Scientist in the Pharmaceutical Development group. In November 2005, he left Baxter and formed BioConvergence LLC with 3 other founders which specialized in developing new formulations and manufacturing processes for parenteral products. In February 2008, he left BioConvergence, which has become a successful company, to form AB BioTechnologies. He is currently the course Director for a 3-day course called Lyophilization Technology which he teaches through the Center for Professional Advancement. He routinely lectures around the world on formulation, stabilization and process development of lyophilized products. He has also been an active member of AAPS since 2001.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
23-07-2012
|
|
|
|
|
|
|
|
Registration:
|
|
For Registration: http://www.complianceonline.com/ecommerce/control/trainingFocus/~product_id=702362?channel=hummolgen
|
|
|
|
|
|
|
|
|